132 results on '"Rejto, Paul A."'
Search Results
2. Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib
3. Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer
4. Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
5. Abstract 4543: Identification of tumor-specific breast cancer expression subtypes and subtype-specific drug response prediction
6. Simulating Disorder-Order Transitions in Molecular Recognition of Unstructured Proteins: Where Folding Meets Binding
7. Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
8. Unraveling Principles of Lead Discovery: From Unfrustrated Energy Landscapes to Novel Molecular Anchors
9. A Mean Field Model of Ligand-Protein Interactions: Implications for the Structural Assessment of Human Immunodeficiency Virus Type 1 Protease Complexes and Receptor-Specific Binding
10. Additional file 6 of Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
11. Abstract A008: PanCAN SPARK: A cloud-based health data integration platform for pancreatic cancer data
12. Abstract PD2-08: Serial genomic profiling reveals molecular mechanisms of breast cancer resistance to palbociclib
13. P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer
14. MOESM2 of Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
15. Deciphering common failures in molecular docking of ligand-protein complexes
16. Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Vivo Limits Glucocorticoid Exposure to Human Adipose Tissue and Decreases Lipolysis
17. Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding
18. TNER: a novel background error suppression method for mutation detection in circulating tumor DNA
19. Statistical method on nonrandom clustering with application to somatic mutations in cancer
20. Visualization of fast energy flow and solvent caging in unimolecular dynamics
21. Abstract LB-215: Analysis of mutations associated with response to glasdegib in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
22. Abstract A08: Mechanistic basis of Palbociclib combinatorial activity in ER+ breast cancer and non-breast indications
23. TNER: a novel background error suppression method for mutation detection in circulating tumor DNA.
24. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine
25. Abstract A43: RB pathway disruption by the CDK4/6 inhibitor palbociclib enhances responses to chemotherapy in squamous cell lung cancer
26. Abstract A42: Palbociclib potentiates nab-paclitaxel efficacy in pancreatic ductal adenocarcinoma
27. Abstract A1-52: Identification of drug-sensitive Notch receptor alterations in human breast cancer
28. Abstract A2-33: Molecular profiling of patient-derived xenograft models across cancers
29. Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression
30. Abstract 4874: OASIS: A centralized portal for cancer omics data analysis
31. PEST Domain Mutations in Notch Receptors Comprise an Oncogenic Driver Segment in Triple-Negative Breast Cancer Sensitive to a γ-Secretase Inhibitor
32. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing
33. Abstract 5144: Epigenetic reprogramming by tumor-derived EZH2 gain of function mutants leads to aggressive 3D-cell morphologies in both epithelial and melanoma cells
34. Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma
35. Cross-species analysis of genetically engineered mouse models of MAPK driven colorectal cancer identifies hallmarks of human disease
36. Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)
37. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
38. Abstract A33: Optimizing NGS-based shRNA screening experiments and data analysis
39. Abstract LB-231: Decoding complex patterns of structural variations in hepatocellular carcinoma.
40. Abstract LB-229: Whole genome sequencing reveals genetic landscape of hepatocellular carcinoma.
41. Abstract 2002: Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
42. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
43. CELL INDEX DATABASE (CELLX): A WEB TOOL FOR CANCER PRECISION MEDICINE.
44. Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models
45. Correction: A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation
46. A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations
47. A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation
48. An Integrated Genomic Approach to Identify Predictive Biomarkers of Response to the Aurora Kinase Inhibitor PF-03814735
49. Abstract LB-220: Molecular predictors of sensitivity to an IGF1R inhibitor in pre-clinical models of lung and colon cancers
50. Abstract 628: A novel SND1-BRAF fusion confers resistance to the cMet inhibitor PF-04217903 in GTL16 cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.